Literature DB >> 309921

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.

M J Berendt, R J North, D P Kirstein.   

Abstract

It was shown that although intravenous administration of bacterial endotoxin caused extensive hemorrhagic necrosis of four different syngeneic murine tumors, only two of these tumors subsequently underwent complete regression: the two that were shown to be immunogeneic as classically defined. An immunologic basis for endotoxin-induced regression was further indicated by the additional findings that regression, but not hemorrhagic necrosis, of the two immunogenic tumors failed to occur in mice that were immunodepressed by whole-body gamma-irradiation, or that were made T-cell deficient by thymectomy and irradiation. That endotoxin-induced regression is T-cell mediated was suggested by the findings that tumor regression was followed by a state of long-lived immunity to a tumor cell challenge implant, and with the possession by the host of T cells that were capable of passively transferring this state of immunity to normal recipients. It is concluded that although parenteral injection of endotoxin causes hemorrhagic necrosis of most solid murine tumors, it is only those tumors that are immunogenic enough to evoke the generation of T-cell-mediated immunity which subsequently go on to completely regress.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 309921      PMCID: PMC2185110          DOI: 10.1084/jem.148.6.1550

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  II. Contribution to the Knowledge of Sarcoma.

Authors:  W B Coley
Journal:  Ann Surg       Date:  1891-09       Impact factor: 12.969

Review 2.  Induction and immunological properties of tumor necrosis factor.

Authors:  M K Hoffmann; H F Oettgen; L J Old; R S Mittler; U Hammerling
Journal:  J Reticuloendothel Soc       Date:  1978-04

3.  Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

Authors:  S Green; A Dobrjansky; M A Chiasson; E Carswell; M K Schwartz; L J Old
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

4.  Absorption of guinea pig serum with agar. A method for elimination of itscytotoxicity for murine thymus cells.

Authors:  A Cohen; M Schlesinger
Journal:  Transplantation       Date:  1970-07       Impact factor: 4.939

5.  Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunity.

Authors:  H T Wepsic; B S Kronman; B Zbar; T Borsos; H J Rapp
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

6.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

7.  Partial purification of a serum factor that causes necrosis of tumors.

Authors:  S Green; A Dobrjansky; E A Carswell; R L Kassel; L J Old; N Fiore; M K Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

8.  Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells.

Authors:  S W Russell; W F Doe; R G Hoskins; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

9.  T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.

Authors:  R J North; D P Kirstein
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA.

Authors:  I Parr; E Wheeler; P Alexander
Journal:  Br J Cancer       Date:  1973-05       Impact factor: 7.640

View more
  39 in total

1.  Mechanistic analysis of high antitumor effect of intradermal administration of lipopolysaccharide from Pantoea Agglomerans.

Authors:  I Iwamoto; S Goto; J Kera; G Soma; S Takeuchi; Y Nagata
Journal:  Med Oncol       Date:  1996-06       Impact factor: 3.064

2.  Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

Review 3.  An overview of the history and biologic properties of tumor necrosis factors.

Authors:  M R Shalaby; D Pennica; M A Palladino
Journal:  Springer Semin Immunopathol       Date:  1986

Review 4.  Modulation of antitumor immunity--immunobiologic approaches.

Authors:  R J North; E S Dye; C D Mills; J P Chandler
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Growing tumors induce hypersensitivity to endotoxin and tumor necrosis factor.

Authors:  J Bartholeyns; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice.

Authors:  N Moriya; H Miwa; K Orita
Journal:  Jpn J Surg       Date:  1984-03

7.  CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.

Authors:  Alice W Yewdall; Scott B Drutman; Felecia Jinwala; Keith S Bahjat; Nina Bhardwaj
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

Review 8.  Toll-like receptors, tissue injury, and tumourigenesis.

Authors:  Savvas Ioannou; Michael Voulgarelis
Journal:  Mediators Inflamm       Date:  2010-09-14       Impact factor: 4.711

9.  Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.

Authors:  E S Dye; R J North; C D Mills
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Generation of enhanced macrophage-mediated antibacterial resistance in animals responding to tumor allografts.

Authors:  M F Newborg; R J North
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.